IDEAYA Biosciences Company

IDEAYA Biosciences (IDEAYA) is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enhancing immunotherapy response, and immuno-oncology therapies targeting the tumor micro-environment. IDEAYA, located in South San Francisco and La Jolla, California, has assembled leading scientists and advisors with extensive knowledge and expertise in cancer biology and small molecule drug discovery.
Technology: Biotechnology, Health Care, Therapeutics
Industry: End-to-end Drug Development
Headquarters: South San Francisco, California, United States
Founded Date: 2015-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 16
Total Funding: 226100000
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-07-07
Last Funding Type: Post-IPO Equity

Visit Website
info@ideayabio.com
Register and Claim Ownership